Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) arose in December 2019
in China rapidly evolving to the Coronavirus Disease 2019 (COVID-19) pandemic. Since …

Indeed, in the study by Dr. Anjan and colleagues, maintenance corticosteroids were
associated with higher rates of hospitalization.[2] As the SARS-CoV-2 pandemic continues …

The clinical characteristics, management, and outcome of coronavirus disease 2019 (COVID-
19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after solid …

SARS-CoV-2 vaccination in solid organ transplant recipients is associated with suboptimal
immune response and risk for breakthrough infection. It is not known whether they are at risk …

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
is challenging health systems all over the world. Particularly high-risk groups show …

Novel Coronavirus‐19 (COVID‐19) in the immunocompromised transplant recipient: #Flatteningthecurve
- Fishman - 2020 - American Journal of Transplantation - Wiley Online Library Skip to Article …

Therapeutic management of solid organ transplant (SOT) recipients infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease …

Abstract Purpose of Review In this review, we aim to summarize the evolution of care for the
solid organ transplant recipient (SOTR) with COVID-19 disease, based on the current …

Coronavirus disease (COVID-19) rapidly progresses to severe acute respiratory syndrome.
This review aimed at collating available data on COVID-19 infection in solid organ …

Since December 2019, increasing attention has been paid to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily …